Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome in Infants with GERD and PPI Therapy
NCT02359604Completed
- Sponsor
- Medical University of Graz
- Start
- Oct 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Medical University of Graz. Primary endpoint: Microbial community profiling of stool at 16 weeks. Started Oct 2014; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02359604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359604.